DiseaseID 4444
急性红白血病
disease
NCI2016_NCI-GLOSS_1602D:Cancer of the blood-forming tissues in which large numbers of immature, abnormal red blood cells are found in the blood and bone marrow.|NCI2016_CDISC_1602D:A progressive, proliferative disease of
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 1Symptom: 1Target: 12Links: 13
Arranging relationship network...
Record Fields
Scalar fields from the final disease record.
- Disease Id
- 4444
- Core Entity Id
- 60792
- Source Entity Count
- 1
- Preferred Name
- Acute Erythroblastic Leukemia
- Name Cn
- 急性红白血病
- Name Pinyin
- Ji Xing Hong Bai Xue Bing
- Name En
- Acute Erythroblastic Leukemia
- Name Latin
- Bilingual Status
- complete
- Disease Type
- disease
- Umls Disease Type
- Neoplastic Process
- Disgenet Type
- disease
- Mesh Class
- Neoplasms; Hemic and Lymphatic Diseases
- Do Class
- Hpo Class
- Mesh Class Name
- Neoplasms; Hemic and Lymphatic Diseases
- Hpo Class Name
- Do Class Name
- Disease Definition
- NCI2016_NCI-GLOSS_1602D:Cancer of the blood-forming tissues in which large numbers of immature, abnormal red blood cells are found in the blood and bone marrow.|NCI2016_CDISC_1602D:A progressive, proliferative disease of blood cells, originating from immature erythroid cells.|NCI2016_02D:The progression of a myelodysplastic syndrome in which there is erythroid predominance into erythroleukemia (M6a or erythroleukemia, erythroid/myeloid).|NCI2016_02D:An acute myeloid leukemia characterized by a predominant immature erythroid population. There are two subtypes recognized: erythroleukemia and pure erythroid leukemia. (WHO, 2001)|NCI2016_02D:Acute erythroid leukemia characterised by the presence of immature erythroid cells in the bone marrow (at least 80% of the cellular component), without evidence of a significant myeloblastic cell population present. -- 2003|NCI2016_02D:Acute erythroid leukemia characterised by the presence of at least 50% erythroid precursors and at least 20% myeloblasts in the bone marrow. -- 2003|MSH2017_2016_08_12:A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.|CSP2006:myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
- Version
- v2
- Suppressed
- No
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Acute Erythroblastic Leukemia
Role
preferred
Name
Leukemia, Erythroblastic, Acute
Role
alias
Cross References
Trusted external identifiers retained for this final record.
Herb
HBDIS001698
Me Sh
D004915
Umls
C0023440
Icd10
C94.0C94.00
Sym Map
SMDE05432
Dis Ge Net
C0023440
Umls Sty
T191
Me Sh Class
C04C15
Tcmbank Disease
29861
Attributes
Merged source attributes and domain-specific metadata.
Version
v2
Suppress
0
Disease Type
disease
Umls Disease Type
Neoplastic Process
Disease Definition
NCI2016_NCI-GLOSS_1602D:Cancer of the blood-forming tissues in which large numbers of immature, abnormal red blood cells are found in the blood and bone marrow.|NCI2016_CDISC_1602D:A progressive, proliferative disease of blood cells, originating from immature erythroid cells.|NCI2016_02D:The progression of a myelodysplastic syndrome in which there is erythroid predominance into erythroleukemia (M6a or erythroleukemia, erythroid/myeloid).|NCI2016_02D:An acute myeloid leukemia characterized by a predominant immature erythroid population. There are two subtypes recognized: erythroleukemia and pure erythroid leukemia. (WHO, 2001)|NCI2016_02D:Acute erythroid leukemia characterised by the presence of immature erythroid cells in the bone marrow (at least 80% of the cellular component), without evidence of a significant myeloblastic cell population present. -- 2003|NCI2016_02D:Acute erythroid leukemia characterised by the presence of at least 50% erythroid precursors and at least 20% myeloblasts in the bone marrow. -- 2003|MSH2017_2016_08_12:A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.|CSP2006:myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
Me Sh Disease Class
Neoplasms; Hemic and Lymphatic Diseases
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
Neoplasms; Hemic and Lymphatic Diseases
Umls Semantic Type Name
Neoplastic Process